35.60

1.60% -0.58

After Hours: 35.60

Atricure Inc (ATRC)

Overview News Price History Option Chain Financials Discussions Forecast

Atricure Inc stock is traded at $35.60, with a volume of 446.99K. It is down -1.60% in the last 24 hours and up +1.51% over the past month. AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Previous Close:

$36.18

Open:

$36.46

24h Volume:

446.99K

Relative Volume:

0.91

Market Cap:

$1.77B

Revenue:

$499.95M

Net Income/Loss:

$-36.36M

P/E Ratio:

-46.23

EPS:

-0.77

Net Cash Flow:

$24.22M

1W Performance:

+2.51%

1M Performance:

+1.51%

6M Performance:

+11.01%

1Y Performance:

+27.87%

1-Day Range:

$35.28

$36.83

1-Week Range:

$33.74

$37.31

52-Week Range:

$27.32

$43.11

Atricure Inc Stock (ATRC) Company Profile

Name

Atricure Inc

Sector

Healthcare (1142)

Industry

Medical Instruments & Supplies (58)

Phone

513-755-4100

Address

7555 INNOVATION WAY, MASON, OH

Employee

1,300

Twitter

@AtriCure

Next Earnings Date

2024-10-29

Latest SEC Filings

ATRC's Discussions on Twitter

Compare ATRC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ATRC Atricure Inc	35.60	1.80B	499.95M	-36.36M	24.22M	-0.77
ISRG Intuitive Surgical Inc	435.73	154.00B	9.15B	2.63B	1.99B	7.1661
BDX Becton Dickinson Co	186.66	53.47B	21.39B	1.61B	2.55B	5.5609
RMD Resmed Inc	273.01	39.70B	5.15B	1.40B	1.65B	9.5082
ALC Alcon Inc	72.60	35.62B	10.03B	1.07B	1.39B	2.1549
WST West Pharmaceutical Services Inc	262.47	18.82B	2.96B	487.70M	344.00M	6.6758

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-17-24	Resumed	JP Morgan	Overweight
Apr-23-24	Upgrade	Oppenheimer	Perform → Outperform
Oct-23-23	Initiated	JMP Securities	Mkt Outperform
Sep-29-23	Initiated	UBS	Buy
Aug-05-21	Downgrade	Oppenheimer	Outperform → Perform
Dec-18-20	Reiterated	Needham	Buy
Nov-06-20	Reiterated	Needham	Buy
Apr-07-20	Initiated	Oppenheimer	Outperform
Feb-06-20	Initiated	BTIG Research	Buy
Jan-24-20	Reiterated	Needham	Buy
Aug-13-19	Downgrade	Northland Capital	Outperform → Market Perform
Apr-12-19	Initiated	JP Morgan	Overweight
Oct-04-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Stifel	Buy
Jun-18-18	Reiterated	Needham	Buy
Apr-27-18	Reiterated	Needham	Buy
Jan-16-18	Reiterated	Needham	Buy
Nov-02-17	Reiterated	Needham	Buy
Jul-28-17	Reiterated	Needham	Buy
May-30-17	Resumed	Piper Jaffray	Overweight
Jun-30-16	Resumed	JMP Securities	Mkt Outperform
Oct-28-15	Reiterated	Needham	Buy
Oct-06-15	Reiterated	Canaccord Genuity	Buy
Oct-06-15	Reiterated	Needham	Buy

View All

Atricure Inc Stock (ATRC) Latest News

11:35 AM

Is AtriCure Inc. stock trading near support levelsEntry Point & AI Powered Market Entry Ideas - newser.com

11:35 AM

11:08 AM

How to build a dashboard for AtriCure Inc. stockInsider Selling & Expert-Curated Trade Recommendations - newser.com

11:08 AM

10:08 AM

Momentum divergence signals in AtriCure Inc. chartWeekly Market Report & AI Optimized Trade Strategies - newser.com

10:08 AM

Applying Elliott Wave Theory to AtriCure Inc.Trade Risk Assessment & AI Based Trade Execution Alerts - newser.com

10:08 AM

01:54 AM

Analyzing drawdowns of AtriCure Inc. with statistical toolsLong Setup & AI Forecasted Entry/Exit Points - newser.com

01:54 AM

Oct 12, 2025

Will AtriCure Inc. see short term momentum2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com

Oct 12, 2025

Oct 11, 2025

Did Analyst Optimism After Q3 Results Just Shift AtriCure's (ATRC) Path to Profitability Narrative? - simplywall.st

Oct 11, 2025

AtriCure, Inc. (NASDAQ:ATRC) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Oct 11, 2025

Oct 10, 2025

Reversal indicators forming on AtriCure Inc. stockJuly 2025 Earnings & Weekly Chart Analysis and Guides - newser.com

Oct 10, 2025

Analyzing AtriCure Inc. with multi timeframe chartsWeekly Risk Summary & High Yield Equity Trading Tips - newser.com

Oct 10, 2025

Oct 09, 2025

AtriCure (NASDAQ:ATRC) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat

Oct 07, 2025

Marks Group Wealth Management Inc Increases Stock Position in AtriCure, Inc. $ATRC - MarketBeat

Oct 07, 2025

Oct 06, 2025

Order flow analysis tools used on AtriCure Inc.July 2025 Sector Moves & Verified Short-Term Plans - newser.com

Oct 06, 2025

Oct 05, 2025

Can AtriCure Inc. hit a new high this monthWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com

Oct 05, 2025

Is now a turning point for AtriCure Inc.July 2025 Catalysts & Real-Time Market Trend Scan - newser.com

Oct 05, 2025

Oct 03, 2025

Medtronic wins CE mark for Penditure LAA exclusion device - MedTech Dive

Oct 03, 2025

Oct 01, 2025

AtriCure (NASDAQ:ATRC) Trading Down 4.9%What's Next? - MarketBeat

Oct 01, 2025

Sep 30, 2025

Dual Epicardial and Endocardial Procedure (DEEP) for Persistent or Longstanding Persistent Atrial Fibrillation - American Heart Association Journals

Sep 30, 2025

What analysts say about AtriCure Inc stockFlag and Pennant Patterns & Wealth Building Starts With One Click - earlytimes.in

Sep 30, 2025

Sep 27, 2025